PUTNAM, CT USA - (February 9, 2017) - Foster Delivery Science and ProMed Pharma have entered into a commercial partnership to provide comprehensive contract services for pharmaceutical and combination device applications. Jointly, the companies will offer thermoplastic and silicone formulation development through production of drug delivery components.
Foster Delivery Science is a leader in blending and extrusion of melt processible polymers and active pharmaceutical ingredients (APIs). These include water soluble, bioresorbable and biodurable thermoplastic formulations. ProMed Pharma offers expertise in silicone formulation technologies, and is a leader in injection molded drug delivery components. Collaboration between the companies will entail marketing, business development, and technical services for a comprehensive range of drug delivery materials and processing technologies.
“Thermoplastics and silicones offer unique benefits for drug delivery applications,” according to Rob Sterling, Director of Business Development for Foster Delivery Science. “Processing these materials with APIs requires different equipment and expertise. This collaboration allows our customers to access a broad range of resources to achieve the best results for their application.”
Dr. James Arps, Director of ProMed Pharma commented “ProMed and Foster have been working on novel drug delivery technologies for many years and we look forward to enhancing our collaborative efforts in support of our customers.”
For more information about the Foster Delivery Science and ProMed Pharma partnership please visit the respective booths, # 2615 and #1808 at MD&M West in Anaheim, CA on February 7-9, 2017, or websites at www.deliveryscience.com and www.promedpharmallc.com.